LILRB2 and hepatocellular carcinoma: Subsequent investigations demonstrated that LILRB2/PirB interacts with ANGPTL8 to activate the ROS/ERK pathway, thereby enhancing autophagy and promoting HCC proliferation (Figure 4A) 196.